INS and metabolic dysfunction-associated steatotic liver disease: Numerous studies have demonstrated that ω3PUFAs are beneficial for NAFLD by reducing intrahepatic triglyceride contents and improving insulin sensitivity in human adults and animals (Alwayn et al., 2005; Levy et al., 2004; Svegliati‐Baroni et al., 2006).